ION-516323

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameION-516323

Drug Alias Namefactor B antisense oligonucleotides (Ionis Pharmaceuticals)factor B antisense oligonucleotides (Isis Pharmaceuticals)ION-588548ION-516323

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionComplement factor B modulatorsAntisense oligonucleotide inhibitors

TargetsComplement factor B

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIonis Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIonis Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A